Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs RELUGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs RELUGOLIX: Safety Overview

Metric NILOTINIB RELUGOLIX
Total FAERS Reports 23,171 20,660
Deaths Reported 4,543 958
Death Rate 19.6% 4.6%
Hospitalizations 4,846 1,699
Average Patient Age 56.5 yrs 72.4 yrs
% Female Patients 47.7% 1.4%
FDA Approval Date Dec 15, 2025 Dec 18, 2020
Manufacturer Novadoz Pharmaceuticals LLC Sumitomo Pharma America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription